Dosing of Intravenous Tocilizumab in a Real-World Setting of Rheumatoid Arthritis: Analyses from the Corrona Registry Dimitrios A. PappasAni JohnJeffrey D. Greenberg Original Research Open access 08 February 2016 Pages: 103 - 115
Collagenase Treatment in Dupuytren Contractures: A Review of the Current State Versus Future Needs Ilse Degreef Review Open access 03 February 2016 Pages: 43 - 51
Real Life Experience of First Course of Anti-TNF Treatment in Ankylosing Spondylitis Patients in Brazil Marina Amaral de Ávila de MachadoAlessandra Maciel AlmeidaFrancisco de Assis Acurcio Original Research Open access 29 January 2016 Pages: 143 - 154
Chronic Diarrhea Associated with High Teriflunomide Blood Concentration André DuquetteAnne Julie FrenetteMaxime Doré Case Report Open access 20 January 2016 Pages: 179 - 185
Effect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study) Takao KoikeMasayoshi HarigaiYoshiya Tanaka Original Research Open access 22 December 2015 Pages: 129 - 141
Living with Psoriatic Arthritis: A Patient’s and Physician’s Perspective Alan SimmonsRoy Fleischmann Commentary Open access 19 December 2015 Pages: 1 - 4
Early Prognostic Factors Associated with the Efficacy of Infliximab Treatment for Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate Satoko HayashiKatsuya SuzukiTsutomu Takeuchi Original Research Open access 11 December 2015 Pages: 155 - 166
Biologics Prescribing for Rheumatoid Arthritis in Older Patients: A Single-Center Retrospective Cross-Sectional Study Klara MorsleyThomas KilnerAlan Steuer Original Research Open access 25 November 2015 Pages: 165 - 172
Consensus Decision Models for Biologics in Rheumatoid and Psoriatic Arthritis: Recommendations of a Multidisciplinary Working Party Jason MadanTony AdesAllan Wailoo Original Research Open access 25 November 2015 Pages: 113 - 125
Influence of Continuing Medical Education on Rheumatologists’ Performance on National Quality Measures for Rheumatoid Arthritis Tamar SapirErica RusieKathleen Moreo Original Research Open access 01 October 2015 Pages: 141 - 151
Delays in Initiation of Disease-Modifying Therapy in Rheumatoid Arthritis Patients: Data from a US-Based Registry Dimitrios A. PappasJeffrey D. KentRobert J. Holt Original Research Open access 29 September 2015 Pages: 153 - 164
Predictors of Atherosclerosis in Ankylosing Spondylitis Inderjeet VermaPawan KrishanAshit Syngle Original Research Open access 30 August 2015 Pages: 173 - 182
Use of Anti-Tumor Necrosis Factor Therapy: A Retrospective Study of Monotherapy and Adherence to Combination Therapy with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs Nicole M. Engel-NitzSarika OgaleMahesh Kulakodlu Original Research Open access 25 August 2015 Pages: 127 - 139
Rituximab for Rheumatoid Arthritis Marc D. CohenEdward Keystone Review Open access 19 August 2015 Pages: 99 - 111
Pharmacokinetics and Bioequivalence Study of Hydroxychloroquine Sulfate Tablets in Chinese Healthy Volunteers by LC–MS/MS Hong-wei FanZhi-xiang MaYing-bin Li Original Research Open access 10 July 2015 Pages: 183 - 195
Epigenetic Aspects of Systemic Lupus Erythematosus Manfred RelleBernd FoehrAndreas Schwarting Review Open access 16 June 2015 Pages: 33 - 46
The Tissue-Selective Estrogen Complex: A Review of Current Evidence Rinu PazhekattuArthur N. LauJonathan D. Adachi Review Open access 20 May 2015 Pages: 47 - 58
Assessing Methotrexate Adherence in Rheumatoid Arthritis: A Cross-Sectional Survey Dana B. DiBenedettiXiaolei ZhouJennie H. Best Original Research Open access 13 May 2015 Pages: 73 - 84
Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis Laura J. SavageMiriam WittmannPhilip S. Helliwell Review Open access 17 March 2015 Pages: 1 - 16
Erratum to: Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis Philip J. Mease Erratum Open access 24 February 2015 Pages: 97 - 97
Characteristics Associated with Biologic Monotherapy Use in Biologic-Naive Patients with Rheumatoid Arthritis in a US Registry Population Dimitrios A. PappasGeorge W. ReedJoel M. Kremer Original Research Open access 27 January 2015 Pages: 85 - 96
Refining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous Tocilizumab Andra F. NegoescuAndrew J. K. Östör Review Open access 25 December 2014 Pages: 17 - 31
Comparison of Biologic Disease-Modifying Antirheumatic Drug Therapy Persistence Between Biologics Among Rheumatoid Arthritis Patients Switching from Another Biologic Stephen S. JohnstonDonna McMorrowSarika Ogale Original Research Open access 23 December 2014 Pages: 59 - 71
Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis Philip J. Mease Review Open access 09 December 2014 Pages: 1 - 20
Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis Terry Ann GlauserEric M. RudermanSheila Kelly Original Research Open access 26 September 2014 Pages: 31 - 44
Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis Martin J. BergmanEric P. ElkinMax I. Hamburger Original Research Open access 23 September 2014 Pages: 21 - 30
Mannitol Preserves the Viscoelastic Properties of Hyaluronic Acid in an In Vitro Model of Oxidative Stress Thierry ConrozierPierre MathieuMarguerite Rinaudo Original Research Open access 25 July 2014 Pages: 45 - 54